-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Kidney Cancer (Renal Cell Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AGENT-797 in Kidney Cancer (Renal Cell Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Kidney Cancer (Renal Cell Cancer) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Transitional Cell Cancer (Urothelial Cell Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AGENT-797 in Transitional Cell Cancer (Urothelial Cell Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Transitional Cell Cancer (Urothelial Cell...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AGENT-797 in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Head And Neck Squamous...
-
Product Insights
Contrast Agents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Contrast Agents Pipeline Market Report Overview The Contrast Agents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Positron Emitting Tomography Contrast Agents ·       Magnetic Resonance Imaging (MRI) Contrast Agents ·       Gadolinium-based MRI Contrast Agents...
-
Product Insights
PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Report Overview A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries. The PTCA Drug Coated Balloon (DCB) Catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed...
-
Thematic Analysis
NewCloud Computing in Travel and Tourism – Thematic Intelligence
Computing in Travel and Tourism - Thematic Intelligence The travel and tourism industry has undergone a sea change in the last few years, moving away from brick-and-mortar travel agents towards online travel. Cloud technologies are the bedrock enabling this change. Cloud investment by travel and leisure companies will reach a significant value by 2028. At its core, cloud computing speeds up product delivery, reducing the time to market. It is also scalable, meaning companies can pay for the exact storage...
-
Sector Analysis
NewContrast Media Injectors Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
The Contrast Media Injectors Market Report Overview The contrast media injectors market size was $1.63 billion in 2023. Factors such as the rising prevalence of chronic diseases and the increased demand for cost-effective and quality healthcare will drive the market growth at a CAGR of more than 4% from 2023 to 2033. Contrast media injectors are devices used to inject contrast media agents into a patient's bloodstream. This process enables the visualization of various pathologies through X-ray, computed tomography, magnetic...
-
Sector Analysis
NewDental Materials Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Dental Materials Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Dental Devices therapeutic area. The model discusses in detail the impact of COVID-19 on dental materials market for the year 2020 and beyond. Dental materials include cements, bonding materials and impression materials, which are used in many dental procedures. Dental Cements, bonding materials and impression materials are used in miscellaneous dental procedures. Dental cements are used for filling...
-
Company Insights
NewM-PESA – Competitor Profile
M-PESA is a mobile-based fund transfer and micro-level banking service available to customers of Safaricom, Kenya’s largest mobile network. Introduced in 2007, the service has become a primary channel for fund transfers in the country. Originally developed as a low-cost microfinance loan repayment system, it was extended as an open platform to remit funds and make consumer payments due to its rising popularity. This was largely a result of factors such as the high cost of remitting funds through banks,...
-
Product Insights
Likelihood of Approval Analysis for Polycythemia Vera
Overview How likely is it that the drugs in Polycythemia Vera will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polycythemia Vera Overview Polycythemia vera (PV) is a stem cell disorder characterized...